GalexAI Medical launches nationwide U.S. audit platform

GalexAI Medical has launched nationwide in the United States with an AI-powered forensic medical record audit platform for patients, attorneys, healthcare organizations and insurers. The company is also entering a strategic partnership and funding phase as it expands its healthcare analytics tools. Why it matters: - GalexAI Medical is targeting a costly pain point in healthcare: finding documentation gaps, clinical deviations and compliance issues inside complex medical records. - The platform aims to give patients, lawyers and healthcare organizations faster access to preliminary review tools that could surface risk before disputes escalate. - The company is also positioning the launch as a step toward future healthcare analytics, LegalTech and risk management products. What happened: - Maikel Nisimblat, founder and CEO of GalexAI Medical, announced the official U.S. launch of the platform on June 17, 2026. - The platform is now available nationwide at More information . - GalexAI Medical says the system is fully operational and actively analyzing complex medical records. The details: - The platform uses artificial intelligence, deep learning and retrieval-augmented generation, or RAG, to run automated medical record audits. - Users can securely upload records and receive a preliminary audit summary that flags potential issues for further review. - Patients and families can access a free preliminary audit with a plain-language summary of findings. - More comprehensive audit reports are available through premium analysis options. - Licensed attorneys can join the company’s attorney network and receive structured forensic audit files that may help evaluate potential medical negligence matters within their jurisdictions. - Healthcare providers, clinics, hospitals and insurers can use the platform for internal quality review to spot documentation inconsistencies, compliance concerns and operational risk indicators. - GalexAI Medical operates as a specialized division of Nisimblat Consulting LLC, a Florida-based company focused on technology-enabled professional services and advanced analytics. - The company’s disclaimer says GalexAI Medical is not a law firm, medical practice, insurance company or healthcare provider. - The disclaimer also says the platform does not provide legal advice, medical advice, diagnoses, treatment recommendations or professional opinions. - Audit results are informational only and should not be treated as legal or medical conclusions. - The release includes a media contact number for Maikel Nisimblat: +1 (561) 757-8159. Between the lines: - The launch mixes a free consumer funnel with a paid professional workflow, suggesting GalexAI Medical wants volume on the front end and higher-value enterprise or attorney use on the back end. - The mention of strategic partnerships and future capital opportunities signals the company is preparing for growth beyond the initial U.S. rollout. - The legal-style disclaimer is important because the platform touches medical and negligence review, areas that can create regulatory and liability risk if the product is overstated. What’s next: - GalexAI Medical says it is evaluating strategic partnerships and future capital opportunities to expand additional AI-driven healthcare analytics and forensic review solutions in the U.S. - The company’s next phase appears to focus on scaling product development and broadening adoption across patients, attorneys and healthcare organizations. - More information is available at the company’s announcement .